Insider filing · ZVRA
Neil F. McFarlane
President and CEO
profile →
Zevra Therapeutics, Inc.
ZVRA · Healthcare · 9 filings in 24 months
ticker →
Neil F. McFarlane sold $727K of Zevra Therapeutics (ZVRA)
Executed Feb 13 2025, disclosed Feb 14 2025, 1 day later.
Value, as filed
$727K
91,817 sh across 2 lots
Executed
Feb 13 2025
the trade date, as filed
Disclosed
Feb 14 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
NMNeil F. McFarlane (President and CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Zevra Therapeutics, Inc. (ZVRA). The largest single filing was $854K of ZVRA (91,000 sh × $9.38, as filed), executed Feb 2.
The name
ZVRAHealthcare · Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United St…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Neil F. McFarlane in ZVRA
ZVRASALE
Zevra Therapeutics, Inc.
$125K14,625 sh × $8.56
Exec Feb 9
Filed Feb 10 · 5:30 PM ET ZVRASALE Zevra Therapeutics, Inc. $854K
91,000 sh × $9.38
Exec Feb 2
Filed Feb 2 · 5:30 PM ET ZVRASALE Zevra Therapeutics, Inc. $211K
19,500 sh × $10.82
Exec Oct 10 2025
Filed Oct 10 2025 · 5:30 PM ET